These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22358341)

  • 1. [Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].
    Melo AS; Macedo CS; Romano LG; Ferriani RA; Navarro PA
    Rev Bras Ginecol Obstet; 2012 Jan; 34(1):4-10. PubMed ID: 22358341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
    BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of common mental disorders in women with polycystic ovary syndrome and its relationship with body mass index.
    Rodrigues CE; Ferreira Lde L; Jansen K; Lopez MR; Drews Júnior CR; Souza LD
    Rev Bras Ginecol Obstet; 2012 Oct; 34(10):442-6. PubMed ID: 23288220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism.
    Melo AS; Vieira CS; Romano LG; Ferriani RA; Navarro PA
    Reprod Sci; 2011 Dec; 18(12):1230-6. PubMed ID: 22096008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome.
    Ni RM; Mo Y; Chen X; Zhong J; Liu W; Yang D
    Eur J Endocrinol; 2009 Sep; 161(3):411-8. PubMed ID: 19542239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
    Diamanti-Kandarakis E; Kouli CR; Bergiele AT; Filandra FA; Tsianateli TC; Spina GG; Zapanti ED; Bartzis MI
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4006-11. PubMed ID: 10566641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Kandaraki EA; Tsourdi EA; Papadakis E; Katsikis I
    Gynecol Endocrinol; 2013 Oct; 29(10):926-30. PubMed ID: 23885694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF; Li X; Zhu MW
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
    Carmina E; Campagna AM; Lobo RA
    Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.